1-8 of 8
Carey K. Anders
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice

Alex Broom, Leah Williams Veazey, Katherine Kenny, Imogen Harper, Michelle Peterie, Alexander Page, Nicole Cort, Jennifer Durling, Eric S. Lipp, Aaron C. Tan, Kyle M. Walsh, Brent A. Hanks, Margaret Johnson, Amanda E.D. Van Swearingen, Carey K. Anders, David M. Ashley, Mustafa Khasraw
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (9): 1670–1677.
https://doi.org/10.1158/1078-0432.CCR-23-0151
Published: 01 May 2023
View article titled, The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice
Open the PDF for The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice in another window
Journal Articles

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

Sarah Jenkins, Wei Zhang, Seth M. Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu, Terri S. Armstrong, Eric Burton, Dee Dee Smart, Ritu Shah, Cody J. Peer, Brett Mozarsky, Oluwatobi Arisa, William D. Figg, Tito R. Mendoza, Elizabeth Vera, Priscilla Brastianos, Scott Carter, Mark R. Gilbert, Carey K. Anders, Roisín M. Connolly, Carol Tweed, Karen L. Smith, Imran Khan, Stanley Lipkowitz, Patricia S. Steeg, Alexandra S. Zimmer
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (8): 1450–1459.
https://doi.org/10.1158/1078-0432.CCR-22-0855
Published: 14 April 2023
View article titled, Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
Open the PDF for Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases in another window
Includes: Supplementary data
Journal Articles

Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases

Sheheryar Kabraji, Jing Ni, Sarah Sammons, Tianyu Li, Amanda E.D. Van Swearingen, Yanzhi Wang, Alyssa Pereslete, Liangge Hsu, Pamela J. DiPiro, Chris Lascola, Heather Moore, Melissa Hughes, Akshara S. Raghavendra, Maria Gule-Monroe, Rashmi K. Murthy, Eric P. Winer, Carey K. Anders, Jean J. Zhao, Nancy U. Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (1): 174–182.
https://doi.org/10.1158/1078-0432.CCR-22-1138
Published: 04 January 2023
View article titled, Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases
Open the PDF for Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases in another window
Includes: Supplementary data
Journal Articles

Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–positive Breast Cancer

Sara M. Tolaney, Solmaz Sahebjam, Emilie Le Rhun, Thomas Bachelot, Peter Kabos, Ahmad Awada, Denise Yardley, Arlene Chan, Pierfranco Conte, Véronique Diéras, Nancy U. Lin, Melissa Bear, Sonya C. Chapman, Zhengyu Yang, Yanyun Chen, Carey K. Anders
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (5): 1582.
https://doi.org/10.1158/1078-0432.CCR-21-0193
Published: 01 March 2021
View article titled, Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–positive Breast Cancer
Open the PDF for Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–positive Breast Cancer in another window
Journal Articles

A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer

Sara M. Tolaney, Solmaz Sahebjam, Emilie Le Rhun, Thomas Bachelot, Peter Kabos, Ahmad Awada, Denise Yardley, Arlene Chan, Pierfranco Conte, Véronique Diéras, Nancy U. Lin, Melissa Bear, Sonya C. Chapman, Zhengyu Yang, Yanyun Chen, Carey K. Anders
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (20): 5310–5319.
https://doi.org/10.1158/1078-0432.CCR-20-1764
Published: 15 October 2020
View article titled, A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer
Open the PDF for A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

The Evolving Modern Management of Brain Metastasis

Peter E. Fecci, Cosette D. Champion, Jacob Hoj, Courtney M. McKernan, C. Rory Goodwin, John P. Kirkpatrick, Carey K. Anders, Ann Marie Pendergast, John H. Sampson
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22): 6570–6580.
https://doi.org/10.1158/1078-0432.CCR-18-1624
Published: 15 November 2019
View article titled, The Evolving Modern Management of Brain Metastasis
Open the PDF for The Evolving Modern Management of Brain Metastasis in another window
Journal Articles

αB-Crystallin: A Novel Regulator of Breast Cancer Metastasis to the Brain

Dmitry Malin, Elena Strekalova, Vladimir Petrovic, Allison M. Deal, Abraham Al Ahmad, Barbara Adamo, C. Ryan Miller, Andrey Ugolkov, Chad Livasy, Karen Fritchie, Erika Hamilton, Kimberly Blackwell, Joseph Geradts, Matt Ewend, Lisa Carey, Eric V. Shusta, Carey K. Anders, Vincent L. Cryns
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (1): 56–67.
https://doi.org/10.1158/1078-0432.CCR-13-1255
Published: 05 January 2014
View article titled, αB-Crystallin: A Novel Regulator of Breast Cancer Metastasis to the Brain
Open the PDF for αB-Crystallin: A Novel Regulator of Breast Cancer Metastasis to the Brain in another window
Includes: Supplementary data
Journal Articles

Poly(ADP-Ribose) Polymerase Inhibition: “Targeted” Therapy for Triple-Negative Breast Cancer

Carey K. Anders, Eric P. Winer, James M. Ford, Rebecca Dent, Daniel P. Silver, George W. Sledge, Lisa A. Carey
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19): 4702–4710.
https://doi.org/10.1158/1078-0432.CCR-10-0939
Published: 29 September 2010
View article titled, Poly(ADP-Ribose) Polymerase Inhibition: “Targeted” Therapy for Triple-Negative Breast Cancer
Open the PDF for Poly(ADP-Ribose) Polymerase Inhibition: “Targeted” Therapy for Triple-Negative Breast Cancer in another window